Ken Griffin’s Hepion Pharmaceuticals HEPA Stock Holding History

Ken Griffin’s Portfolio HEPA Stock Details HEPA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-35	Closed	-$69K	–	14137
2021 Q2	$69K	Buy	35 +12	+52%	+$22K	﹤0.01%	13169
2021 Q1	$43K	Sell	23 -3	-12%	-$6.58K	﹤0.01%	12955
2020 Q4	$56K	Buy	+26	New	+$67.4K	﹤0.01%	10527

Other funds holding HEPA

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Ken Griffin's HEPA Position: Q2 2025 in Review

Ken Griffin sold out of Hepion Pharmaceuticals (HEPA) in Q2 2025, closing a stake of 15,581 shares — an estimated $6.7K sold.

Ken Griffin first reported a position in HEPA in Q4 2018 and held it in 13 quarters. The position peaked at $114K in Q2 2021. 4 funds tracked by Wall St. Rank hold HEPA as of Q2 2025.

Ken Griffin reported no remaining Hepion Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
Ken Griffin sold 15,581 Hepion Pharmaceuticals shares in Q2 2025, an estimated $6.7K.
Ken Griffin first reported a position in Hepion Pharmaceuticals in Q4 2018 and held it in 13 quarters.
Ken Griffin's Hepion Pharmaceuticals position peaked at $114K in Q2 2021.
4 funds tracked by Wall St. Rank held Hepion Pharmaceuticals as of Q2 2025.

Based on Citadel Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.